126 related articles for article (PubMed ID: 37740714)
21. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
[TBL] [Abstract][Full Text] [Related]
22. Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images.
Li L; Liu W; Cai Q; Liu Y; Hu W; Zuo Z; Ma Q; He S; Jin K
Front Immunol; 2023; 14():1152235. PubMed ID: 37409120
[TBL] [Abstract][Full Text] [Related]
23. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
[TBL] [Abstract][Full Text] [Related]
24. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
Dadar M; Mahmoud S; Narayanan S; Collins DL; Arnold DL; Maranzano J
Brain; 2022 Jun; 145(6):2008-2017. PubMed ID: 34927199
[TBL] [Abstract][Full Text] [Related]
25. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
[TBL] [Abstract][Full Text] [Related]
26. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.
Dwyer MG; Bergsland N; Ramasamy DP; Jakimovski D; Weinstock-Guttman B; Zivadinov R
J Neuroimaging; 2018 Sep; 28(5):490-495. PubMed ID: 29856910
[TBL] [Abstract][Full Text] [Related]
27. Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis.
Bergsland N; Dwyer MG; Jakimovski D; Tavazzi E; Benedict RHB; Weinstock-Guttman B; Zivadinov R
Neurology; 2023 Feb; 100(9):e911-e920. PubMed ID: 36543575
[TBL] [Abstract][Full Text] [Related]
28. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis.
Furby J; Hayton T; Anderson V; Altmann D; Brenner R; Chataway J; Hughes R; Smith K; Miller D; Kapoor R
Mult Scler; 2008 Sep; 14(8):1068-75. PubMed ID: 18632782
[TBL] [Abstract][Full Text] [Related]
30. Leptomeningeal enhancement on post-contrast FLAIR images for early diagnosis of Susac syndrome.
Bellanger G; Biotti D; Adam G; Darcourt J; Roques M; Patsoura S; Savatovsky J; Obadia M; Menjot de Champfleur N; Charif M; Labauge P; Cotton F; Durand Dubief F; Tourdias T; Dulau C; Kremer S; De Sèze J; Ciron J; Varenne F; Viguier A; Lerebours F; Larrue V; Cognard C; Bonneville F
Mult Scler; 2022 Feb; 28(2):189-197. PubMed ID: 33988466
[TBL] [Abstract][Full Text] [Related]
31. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
[TBL] [Abstract][Full Text] [Related]
32. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
[TBL] [Abstract][Full Text] [Related]
33. MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis.
Koch MW; Mostert J; Repovic P; Bowen JD; Strijbis E; Uitdehaag B; Cutter G
Mult Scler; 2022 Apr; 28(4):561-572. PubMed ID: 34304609
[TBL] [Abstract][Full Text] [Related]
34. Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis.
Calvi A; Tur C; Chard D; Stutters J; Ciccarelli O; Cortese R; Battaglini M; Pietroboni A; De Riz M; Galimberti D; Scarpini E; De Stefano N; Prados F; Barkhof F
Neuroimage Clin; 2022; 35():103048. PubMed ID: 35598462
[TBL] [Abstract][Full Text] [Related]
35. Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.
D'hooghe MB; Gielen J; Van Remoortel A; D'haeseleer M; Peeters E; Cambron M; De Keyser J; Nagels G
J Magn Reson Imaging; 2019 May; 49(5):1312-1321. PubMed ID: 30597656
[TBL] [Abstract][Full Text] [Related]
36. Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy.
Slezáková D; Kadlic P; Jezberová M; Boleková V; Valkovič P; Minar M
Neurol Neurochir Pol; 2023; 57(3):282-288. PubMed ID: 37144903
[TBL] [Abstract][Full Text] [Related]
37. Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.
Bose G; Healy BC; Saxena S; Saleh F; Paul A; Barro C; Lokhande HA; Polgar-Turcsanyi M; Anderson M; Glanz BI; Guttmann CRG; Bakshi R; Weiner HL; Chitnis T
Mult Scler Relat Disord; 2023 Jun; 74():104695. PubMed ID: 37060852
[TBL] [Abstract][Full Text] [Related]
38. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
[TBL] [Abstract][Full Text] [Related]
39. Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact.
Kim H; Lim DH; Kim TG; Lee JI; Nam DH; Seol HJ; Kong DS; Choi JW; Suh YL; Kim ST
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e366-e373. PubMed ID: 29473335
[TBL] [Abstract][Full Text] [Related]
40. T2 lesions and rate of progression of disability in multiple sclerosis.
Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
